Gabapentin in late-onset poststroke seizures. 2002

J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
Cerebrovascular Unit, Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain. alsa@hg.vhebron.es

Stroke is a frequent cause of epileptic seizures (ES) in adults. The authors evaluated the long-term efficacy and tolerability of gabapentin (900 to 1,800 mg/day) in 71 patients with a first poststroke late ES during a mean follow-up time of 30 months. ES recurred in 18.3% of the patients and side effects were noted in 27 cases (38%), but only two (2.8%) required discontinuation or early withdrawal. Gabapentin monotherapy was useful and safe for late poststroke ES.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003509 Cyclohexanecarboxylic Acids Carboxylic acid derivatives of cyclohexane. Acids, Cyclohexanecarboxylic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
October 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
October 2008, Epilepsy & behavior : E&B,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
January 1993, Rinsho shinkeigaku = Clinical neurology,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
March 1997, Epilepsia,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
May 2006, Epilepsy & behavior : E&B,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
June 1995, Alcoholism, clinical and experimental research,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
February 2002, Archives of neurology,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
March 1994, Topics in stroke rehabilitation,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
August 1995, The American journal of psychiatry,
J Alvarez-Sabín, and J Montaner, and L Padró, and C A Molina, and R Rovira, and A Codina, and M Quintana
February 1989, Acta neurologica Scandinavica,
Copied contents to your clipboard!